SimBioSys

Chicago, United States

SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.

$15.0M raised

Oct 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SimBioSys raised?

SimBioSys has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.

Who are SimBioSys's investors?

SimBioSys's investors include AV8 Ventures, Mayo Clinic, Genoa Ventures, Northpond Ventures, Heritage Group.

Where is SimBioSys headquartered?

SimBioSys is headquartered in Chicago, United States.

What does SimBioSys do?

SimBioSys is developing a Computational Microscope to provide new insight into the behavior of cancers.

What stage is SimBioSys at?

SimBioSys is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 26, 2021.

MLA

"SimBioSys — Funding & Investors." VCBacked, October 26, 2021, https://www.vcbacked.co/company/simbiosys. Accessed July 4, 2026.

APA

VCBacked. (2021). SimBioSys — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/simbiosys

Wikipedia (cite web)

{{cite web |title=SimBioSys — Funding & Investors |url=https://www.vcbacked.co/company/simbiosys |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 26, 2021.